Vaidya Sane Ayurved Laboratories Quarterly Results for Trading Insights
MADHAVBAUG • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹235 Cr
QSept 2023
Vaidya Sane Ayurved Laboratories Quarterly Results Key Highlights
- Revenue of ₹5,173 Cr in Sept 2023 (+11.5% vs Jun 2023, -48.5% vs Sept 2022)
- Net Profit of ₹235 Cr in Sept 2023 (-4.9% vs Jun 2023, -75.7% vs Sept 2022)
- EBITDA of ₹332 Cr in Sept 2023 (-33.6% vs Jun 2023)
- Operating Margin of 5.0% in Sept 2023 (-4.0pp vs Jun 2023)
- Earnings Per Share of ₹1.12 in Sept 2023 (-56.9% vs Jun 2023)
Vaidya Sane Ayurved Laboratories Quarterly Results Analysis
| Metric | Sept 2023 | Jun 2023 | Sept 2022 | QoQ | YoY |
|---|---|---|---|---|---|
| Revenue (₹ Cr) | 5,173 | 4,641 | 10,053 | 11.5% | -48.5% |
| Net Profit (₹ Cr) | 235 | 247 | 967 | - | - |
| EBITDA (₹ Cr) | 332 | 500 | 922 | - | - |
| EPS (₹) | 1.12 | 2.60 | 4.60 | - | - |
| Operating Margin (%) | 5.0% | 9.0% | 8.0% | - | - |
Vaidya Sane Ayurved Laboratories Share Price Trend Around Quarterly Results
Visualize Vaidya Sane Ayurved Laboratories's 1-year price movement across quarterly results — ideal for logging trades in Vaidya Sane Ayurved Laboratories share price
chart using Tickjournal. All values in ₹.
Related Pages for Vaidya Sane Ayurved Laboratories
Additional stock information and data for MADHAVBAUG
Revenue Trend (₹ Cr)
Sept 2022
10,053
Jun 2023
4,641
Sept 2023
5,173
Net Profit Trend (₹ Cr)
Sept 2022
967
Jun 2023
247
Sept 2023
235
Operating Margin Trend (%)
Sept 2022
8.0%
Jun 2023
9.0%
Sept 2023
5.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Vaidya Sane Ayurved Laboratories quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹417,052.40 Cr | 1729.9 | 14,875 | 3,125 | +10.8% | - | 21.0% | 133.1 |
|
Divis Laboratories
Sept 2025 |
₹176,337.50 Cr | 6616.5 | 2,860 | 689 | +7.1% | - | 24.1% | 254.8 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹136,522.12 Cr | 3963.4 | 3,219 | 591 | +11.3% | - | 18.4% | 226.0 |
|
Cipla
Sept 2025 |
₹118,572.82 Cr | 1465.7 | 7,716 | 1,353 | +12.0% | - | 17.5% | 87.6 |
|
Dr Reddys Laborator…
Sept 2025 |
₹100,998.62 Cr | 1210.1 | 9,135 | 1,337 | +1.1% | - | 14.6% | 74.8 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores